F.D.A. Approves Drug to Treat Pain Without Opioid Effects
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug Administration approved a new medication Thursday to treat pain from an injury or surgery. It is expensive, with a list price of $15.50 per pill. But unlike opioid pain medicines, it cannot become addictive.
FDA approves first new non-opioid painkiller in decades, and it's from a MA company.
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company Vertex Pharmaceuticals on Thursday. The drug, which is called suzetrigine and will be sold under the brand name Journavx, is the first new type of pain medicine approved by the agency in more than 20 years.
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non-opioid painkiller since that class first appeared on the market in the 1980s.
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November,
FDA approves opioid-free pain medication with 'no sign of addiction'
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients. Doctors share what patients should know about the drug.
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
Journavx: What to know about new FDA-approved non-opioid pain medication
The U.S. Food and Drug Administration (FDA) created a major media stir last week when it announced the approval of suzetrigine (brand name Journavx), a unique new non-opioid, non-addictive drug for the treatment of moderate to severe acute pain.
FDA approves new non-addictive painkiller alternative to opioids
Vanguard just issued a crucial warning for future retirees — here’s why ‘retirement is changing’ and how to prepare Jason and Kylie Kelce reveal Super Bowl loyalties amid conflicting ties to Chiefs, Eagles Blue Bell Just Launched a New Flavor Fans Are Calling the 'Best Ice Cream Ever' Second federal judge orders temporary pause to Trump administration efforts to freeze funding ISRO's GSLV-F15 successfully launched NVS-02,
FDA approves non-opioid pain medication as new alternative for pain relief
The US Food and Drug Administration (FDA) has approved a new pain medication, suzetrigine, marking the first new type of pain reliever to be approved in over 20 years.The drug, sold under the brand name Journavx,
Broccoli and chocolate, fish and chips: Class 1 recalls for products sold in Oregon
The (FDA) has announced several Class 1 recalls, the highest risk level, for various food products sold across multiple ...
Moscow-Pullman Daily News1d
The story of food additives and banning of Red Dye No. 3
You may have heard in the news that the U.S. Food and Drug Administration will no longer allow the use of FD&C Red Dye No. 3 ...
Food and Drug Administration wants to put nutrition labels front and center on food products
The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...
MUI KITCHEN US (English) on MSN8h
Food-Related Topics RFK Jr. Will Present at Senate Confirmation Hearing
The hearing is expected to be contentious due to Kennedy's controversial views. "This is the most important hearing of all ...
US FDA approves Axsome Therapeutics' migraine drug
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
JD Supra2d
FDA Bans Red Dye No. 3 in Food and Ingested Drugs: What Manufacturers Should Know
On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...
Broccoli sold at Walmart in OR, WA, and other states recalled over Listeria concerns
Braga Fresh has voluntarily recalled certain 12-ounce bags of Marketside Broccoli Florets sold at Walmart locations across 20 ...
More than 5,000 lbs of pet food recalled due to Salmonella risk
CINCINNATI (WKRC) - A pet food manufacturer has issued a recall due to Salmonella contamination. Blue Ridge Beef recalled ...